Cencora (COR) Competitors

Elevance Health (NYSE:ELV) and Cencora (NYSE:COR) are both large-cap medical companies, but which is the better stock? We will compare the two businesses based on the strength of their analyst recommendations, risk, earnings, institutional ownership, media sentiment, dividends, valuation and profitability.

Is ELV or COR more profitable?

Elevance Health has a net margin of 2.83% compared to Cencora's net margin of 0.55%. Cencora's return on equity of 344.71% beat Elevance Health's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Elevance Health	2.83%	17.59%	6.36%
Cencora	0.55%	344.71%	4.26%

Do institutionals and insiders believe in ELV or COR?

89.2% of Elevance Health shares are owned by institutional investors. Comparatively, 97.5% of Cencora shares are owned by institutional investors. 0.3% of Elevance Health shares are owned by company insiders. Comparatively, 10.8% of Cencora shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock will outperform the market over the long term.

Which has more volatility and risk, ELV or COR?

Elevance Health has a beta of 0.6, indicating that its share price is 40% less volatile than the S&P 500. Comparatively, Cencora has a beta of 0.57, indicating that its share price is 43% less volatile than the S&P 500.

Is ELV or COR a better dividend stock?

Elevance Health pays an annual dividend of $6.84 per share and has a dividend yield of 2.5%. Cencora pays an annual dividend of $2.20 per share and has a dividend yield of 0.7%. Elevance Health pays out 29.1% of its earnings in the form of a dividend. Cencora pays out 25.5% of its earnings in the form of a dividend. Both companies have healthy payout ratios and should be able to cover their dividend payments with earnings for the next several years. Elevance Health has raised its dividend for 14 consecutive years and Cencora has raised its dividend for 15 consecutive years.

Does the media refer more to ELV or COR?

In the previous week, Elevance Health had 66 more articles in the media than Cencora. MarketBeat recorded 87 mentions for Elevance Health and 21 mentions for Cencora. Cencora's average media sentiment score of 1.54 beat Elevance Health's score of 0.50 indicating that Cencora is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Elevance Health	33 Very Positive mention(s)	9 Positive mention(s)	17 Neutral mention(s)	14 Negative mention(s)	2 Very Negative mention(s)	Neutral
Cencora	19 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Very Positive

Do analysts recommend ELV or COR?

Elevance Health presently has a consensus target price of $435.93, suggesting a potential upside of 56.68%. Cencora has a consensus target price of $309.83, suggesting a potential upside of 5.60%. Given Elevance Health's higher probable upside, analysts plainly believe Elevance Health is more favorable than Cencora.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Elevance Health	0 Sell rating(s)	6 Hold rating(s)	11 Buy rating(s)	0 Strong Buy rating(s)	2.65
Cencora	0 Sell rating(s)	3 Hold rating(s)	9 Buy rating(s)	0 Strong Buy rating(s)	2.75

Which has preferable earnings & valuation, ELV or COR?

Elevance Health has higher earnings, but lower revenue than Cencora. Elevance Health is trading at a lower price-to-earnings ratio than Cencora, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Elevance Health	$177.01B	0.35	$5.98B	$23.50	11.84
Cencora	$293.96B	0.19	$1.51B	$8.62	34.04

Summary

Elevance Health beats Cencora on 10 of the 19 factors compared between the two stocks.